drugset / Trial / NCT00253084
Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to compare the clinical efficacy of IPX054 to immediate-release carbidopa-levodopa in subjects with Parkinson's disease.
Timeline
- Start
- 2005-11
- Primary completion
- 2007-12
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carbidopa | Unknown | 25 mg | — |
| Subject | Carbidopa | Unknown | 50 mg | — |
| Subject | Levodopa | Unknown | 100 mg | — |
| Subject | Levodopa | Unknown | 200 mg | — |